Skip to main content
Download PDF

CircRNA/miRNA/mRNA axis participates in the progression of partial bladder outlet obstruction

BMC Urology volume 22, Article number: 191 (2022) Cite this article

Abstract

Background

More and more evidence showed that circRNA/miRNA/mRNA axis played a vital role in the pathogenesis of some diseases. However, the role of circRNA/miRNA/mRNA axis in partial bladder outlet obstruction (pBOO) remains unknown. Our study aimed to explore the complex regulatory mechanism of circRNA/miRNA/mRNA axis in pBOO.

Methods

The pBOO rat model was established, and the bladder tissues were collected for mRNA sequencing. The differentially expressed mRNAs were analyzed by high-throughput sequencing, and the GO and KEGG analysis of the differentially expressed mRNAs were performed. Competing endogenous RNAs (ceRNAs) analysis identified the potential regulation function of circRNA/miRNA/mRNA axis in pBOO. qRT-PCR detected the expression of circRNA/miRNA/mRNA. miRanda software was performed to predict the relationship between circRNA and miRNA, miRNA and mRNA.

Results

Compared with the sham group, a total of 571 mRNAs were differentially expressed in the pBOO group, of which 286 were up-regulated and 285 were down-regulated. GO analysis showed that the mRNAs were mainly involved in cellular process, single-organism process, and cell, etc. KEGG analysis showed that the enriched signaling pathways were metabolic pathways, cell adhesion molecules (CAMs), and HTLV-I infection, etc. Based on the previous transcriptome data and differentially expressed circRNAs, we drew the ceRNA network regulation diagram. qRT-PCR results confirmed that chr3:113195876|113197193/rno-miR-30c-1-3p/Gata4, chr1:126188351|126195625/rno-miR-153-5p/Diaph3, and chr9:81258380|81275269/rno-miR-135b-5p/Pigr axis may have ceRNA function. miRanda confirmed there have the binding sites of circRNA/miRNA/mRNA axis.

Conclusions

CircRNA/miRNA/mRNA axis was involved in the progression of pBOO. Our research on the circRNA/miRNA/mRNA axis revealed new pathogenesis and treatment strategies for pBOO.

Peer Review reports

Introduction

Partial bladder outlet obstruction (pBOO) is a common urinary disease, which is commonly seen in clinical benign prostatic hyperplasia (BPH), bladder neck contracture, urethral stricture, congenital urethral malformation and bladder neck tumor, among which BPH is the most common cause of pBOO [1,2,3]. Studies have shown that pBOO is the initiating factor of the physiological and pathological cascade that leads to deep changes in the structure and function of the bladder [4]. pBOO can trigger inflammatory response in the bladder, accompanied by urodynamic changes of bladder function, leading to organ fibrosis and eventually loss of contractile ability [5]. However, partial pBOO can increase systemic and tissue oxidative stress [6]. In addition to the removal of obstruction by operation, prevention of secondary bladder fibrosis and protection of upper urinary tract function are the key points of pBOO treatment [7]. However, the mechanism of bladder fibrosis after pBOO has not yet been fully clarified at present, and there are still no ideal biomarkers for diagnosis, monitoring and treatment of pBOO. Therefore, there is an urgent need to develop new strategies for the treatment of pBOO.

In the transcriptome, many protein-coding mRNAs and non-protein-coding transcripts are closely related to the pathogenesis of diseases [8, 9]. Circular RNA (circRNA)/microRNA (miRNA)/mRNA axis plays an increasingly vital role in disease progression [10, 11]. CircRNAs were identified as the new star of endogenous non-coding RNAs [12]. CircRNAs competitively bind to miRNA response elements, act as natural miRNA sponges, regulate downstream mRNA expression, and are involved in many human physiology and pathology by competing endogenous RNA (ceRNA) mechanisms [13, 14]. CeRNA forms a large-scale and complex regulatory network in the whole transcriptome, which greatly expands the functional genetic information in the human genome [15]. In addition, RNA sequencing technology has been widely used for effective target screening, especially in biological applications [16]. RNA-sequencing analysis is an open system for discovering new genetic information and has been applied to potential targets of several diseases [17]. Previous studies revealed miRNA may play a role in regulating urothelial permeability and bladder contractility [18, 19]. In view of these data, circRNA/miRNA/mRNA axis may play a crucial part in pBOO, but the regulatory pathway remains unknown.

In the previous study, female Sprague Dawley rats were used to construct a model of pBOO, and then the bladder tissues were collected. High-throughput sequencing was used to analyze the differentially expressed circRNAs in the bladder tissues, and preliminarily determined that circRNAs can participate in the progress of pBOO [20]. In this study, we constructed the pBOO model, and then analyzed the expression profile of mRNAs. The expression profile of mRNAs was analyzed through gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) to reveal the possible pathogenesis of pBOO. CeRNAs network were established to further elucidate the complex pBOO regulation mechanism. Our findings may provide a new perspective on the pathogenesis and potential diagnosis of pBOO, and contribute to the discovery of potential therapeutic targets for pBOO.

Material and methods

Animal

Healthy female Sprague Dawley rats, aged 10 weeks, weighing 200–250 g, were provided by the Southern Medical University (Guangzhou, China). The 16 SD rats were randomly divided into sham and pBOO groups with 8 rats in each group. During the experiment, the animals grew under natural conditions, with the temperature set to 21–24 °C and humidity at 50–70%. The study was carried out in compliance with the ARRIVE guidelines. This animal experiment was approved by Experimental Animal Care and Usage Committee of the Six Affiliated Hospital of Guangzhou Medical University (Qingyuan People’s Hospital) (Qingyuan, China).

Establishment of the pBOO model

According to the previous studies, we built pBOO rats model [21, 22]. In short, rats expose the bladder and proximal urethra through an incision in the lower abdomen under anesthesia with isoflurane. Through careful observation, the proximal urethra was away from the vaginal wall to avoid damage to the peripheral blood vessels. A metal rod with a diameter of 1 mm is placed next to the proximal urethra, and 4–0 polypropylene ligature is tied around the urethra and the metal rod to cause obstruction. The metal rod was then removed and the abdominal incision was closed. In the sham group, following the same procedure, the suture was loosely tied around the urethra without obstruction. Ten days after surgery, bladder tissue was taken from these rats for mRNAs sequencing.

High-throughput sequencing

Total RNA from bladder tissues was extracted with the TRIzol™ reagent (Invitrogen, CA, USA) according to the manufacturer’s instructions. The Ribo-Zero Gold RNA removal Kit (Illumina, San Diego, CA, USA) was used to remove the ribosomal RNA. The rRNA-depleted RNAs were further incubated at 37 °C for 1 h with 10 U/μg RNase R (Thermo Fisher Scientific). The remaining RNAs were used to construct cDNA libraries, according to the protocol of the mRNA-Seq sample preparation kit (Illumina, San Diego, CA, USA). The sequencing instrument used was Illumina Hiseq2500 platform, and the sequencing mode used was PEl50.

Data analysis

The average sequencing depth of six samples was 6.41G.The quality of sequenced reads was controled by FastQC (v0.11.3) [23] and the clean reads were mapped to the rat reference genome (Rn6) by HISAT2 (2.1.0) [24]. The DESeq2 package (1.32.0) in R 3.3.2 software was also used to process quantile normalization and analyze the differentially expressed mRNAs. The mRNAs with |log2fold change|≥ 1 and P < 0.05 were considered as differentially expressed. The expression patterns of the mRNAs among the samples were obtained using hierarchical clustering.

GO and KEGG enrichment analysis

GO enrichment analyses of differentially expressed mRNAs between the sham and pBOO groups were conducted using the Bioinformatics Tool (DAVID, version 6.8, https://david.ncifcrf.gov/) [25, 26]. KEGG pathway enrichment analyses were performed using the KOBAS 2.0 software to clarify differentially expressed mRNAs-related signaling pathways [27].

Construction of the ceRNA network

With the deepening of transcriptome research, miRNA response elements have been found to exist on circRNA, which means that the same miRNA can bind to multiple types of RNA and form a competitive relationship with different RNA molecules bound with the same miRNA [15]. The differentially expressed circRNAs were determined based on previous studies [20]. Combined with differentially expressed mRNAs (|log2fold change| ≥ 1 and P < 0.05) and differentially expressed circRNAs (|log2fold change| ≥ 1 and P < 0.05), a potential ceRNA network was constructed by base pairing and integrating the predicted results. In order to explore circRNA/miRNA/mRNA role in the pathogenesis of pBOO, Cytoscape software (version 3.7.2) was used to visualize the results.

Quantitative real-time PCR (qRT-PCR)

qRT-PCR was applied to test the relative expression levels of chr3:113195876|113197193, rno-miR-30c-1-3p, Gata4, chr5:122655270|122671094, rno-miR-185-3p, chr1:126188351|126195625, rno-miR-153-5p, Diaph3, chr9:81258380|81275269, rno-miR-135b-5p, and Pigr in bladder tissues. In short, total RNA was extracted by Trizol method, RNA was reversely transcribed into cDNAs in accordance with the instruction of a Reverse transcription kit (CW2569, CWBIO, China). The relative expression of genes was tested by SYBR Green qPCR mix (Invitrogen) on ABI 7900 system. The internal reference gene was GAPDH and U6, and 2−ΔΔCt method was used to calculate the relative transcription level of the target gene. The primer sequences used in this study are showed in Table 1.

Table 1 The primer sequences used in this study
Full size table

Bioinformatics analysis

We used miRanda (version 0.10.80) software to predict the relationship between circRNAs and miRNAs, miRNAs and mRNAs. The binding sites of chr3:113195876|113197193 and rno-miR-30c-1-3p, rno-miR-30c-1-3p and Gata4, chr1:126188351|126195625 and rno-miR-153-5p, rno-miR-153-5p and Diaph3, chr5:122655270|122671094 and rno-miR-185-3p, rno-miR-185-3p and Pigr were detected.

Statistical analysis

Data were presented as the mean ± standard deviation (SD) and evaluated by the Graphpad 8.0 software. All data were firstly subjected to Shapiro–Wilk normality test. 2 tailed unpaired Student’s T-test or one-way ANOVA test shall be conducted for data with normal distribution, and Mann Whitney test or Kruskal Wallis ANOVA test shall be conducted for data with non normal distribution. P < 0.05 was considered as statistically significant.

Results

High-throughput sequencing analysis of differentially expressed mRNAs

In order to further explore the mechanism of circRNA/miRNA/mRNA regulation of pBOO, we used high-throughput sequencing to analyze the differentially expressed mRNAs in the bladder tissues.

As shown in Fig. 1A, there are 18,091 mRNAs commonly expressed in the sham and pBOO groups. In addition, 784 mRNAs were unique to the sham group and 1037 mRNAs were unique to the pBOO group. Figure 1B showed the number of mRNAs differentially expressed on different chromosomes. The green and red columns represent the number of down-regulated and up-regulated mRNAs in pBOO, respectively. Hierarchical clustering analysis was first used to reveal the expression profiles of 571 differentially expressed mRNAs (|log2fold change| ≥ 1 and P < 0.05) between the sham and pBOO groups, of which 286 were up-regulated and 285 were down-regulated (Fig. 1C). GO analysis clarified functional annotations including biological processes (BP), cellular components (CC), and molecular functions (MF) (Fig. 1D). CC reflects that differentially expressed mRNA is distributed in different cell components. MF showed that mRNA related to binding, catalytic activity and molecular transducer activity was the most common. BP shows that cellular process is the most disturbed biological process. Next, KEGG analysis was used to determine the top 20 enrichment pathways. The signaling pathways that changed in the sham, pBOO groups were: metabolic pathways, cell adhesion molecules (CAMS), and HTLV-I infection, etc. (Fig. 1E). Therefore, based on the above results, we were able to successfully screen the mRNAs in pBOO rats.

Fig. 1
figure 1

High-throughput sequencing analysis of differentially expressed mRNAs. A Venn diagrams of mRNAs were identified in sham and pBOO groups. B Number of differential expression mRNAs from different chromosomes. Green and red columns represent numbers of down-regulated and up-regulated mRNAs in pBOO. C Heat map (left) and volcano map (right) of differentially expressed mRNAs. D GO analysis diagram of differentially expressed mRNAs. E KEGG analysis was used to determine the top 20 enrichment pathways

Full size image

The ceRNA network regulation diagram of circRNA/miRNA/mRNA

Based on the previous transcriptome data and differentially expressed circRNAs, we combined with the differentially expressed mRNAs (|log2fold change| ≥ 1 and P < 0.05, a total of 571) and differentially expressed circRNAs (|log2fold change| ≥ 1 and P < 0.05, a total of 3051) to make ceRNA mechanism form. The ceRNA general network regulation diagram of circRNA/miRNA/mRNA was drawn according to the increase or decrease of circRNA and mRNA expression, and the miRNA binding sites in circRNAs and mRNA were more than 3 (Fig. 2A). Among them, there were 38 circRNAs with up-regulated expression and 79 circRNAs with down-regulated expression. Then we screened target genes that are related to bladder function, and numTargetsPer100 bp are greater than 0.2, and draw a ceRNA network diagram (Fig. 2B). Among them, there are 22 circRNAs with up-regulated expression and 24 circRNAs with down-regulated expression. Next, we screened the miRNAs related to bladder function and drew ceRNA network diagram. Among them, there were 14 circRNAs with up-regulated expression and 13 circRNAs with down-regulated expression (Fig. 2C). Finally, in the filter result of Fig. 2B, we further screened the circRNAs origin genes related to bladder function and drew ceRNA network diagram. There were 3 circRNAs with up-regulated expression and 5 circRNAs with down-regulated expression (Fig. 2D). Therefore, next we verified the circRNA/miRNA/mRNA in pBOO rats.

Fig. 2
figure 2

The ceRNA network regulation diagram of circRNA/miRNA/mRNA. A The ceRNA total network regulation diagram of circRNA/miRNA/mRNA. B The network diagram of ceRNA that target genes are related to bladder function, and numTargetsPer100 bp are greater than 0.2. C and D The network diagram of ceRNA that the miRNAs and circRNAs origin genes are related to bladder function, respectively

Full size image

The identification of the screened circRNA/miRNA/mRNA axis

Next, we used qRT-PCR to detect the expression of circRNA/miRNA/mRNA to explore the mechanism of pBOO. The results showed that, compared with the sham group, chr5:122655270|122671094, chr1:126188351|126195625, rno-miR-30c-1-3p, rno-miR-185-3p, rno-miR-135b-5p, and Diaph3 were up-regulated in pBOO group, while chr3:113195876|113197193, chr9:81258380|81275269, rno-miR-153-5p, Gata4, and Pigr were down-regulated (Fig. 3). Among them, chr3:113195876|113197193/rno-miR-30c-1-3p/Gata4, chr1:126188351|126195625/rno-miR-153-5p/Diaph3, and chr9:81258380|81275269/rno-miR-135b-5p/Pigr axis might have ceRNA function. It is worth noting that the expression of rno-miR-135b-5p in BOO group is about 19 times that of sham group, which is more obvious than other molecules, suggesting that this molecule may play a more important role in the regulation of BOO process.

Fig. 3
figure 3

qRT-PCR was used to detect the expression of circRNA/miRNA/mRNA. *P < 0.05 VS sham group

Full size image

miRanda analyzed the binding sites of circRNA/miRNA/mRNA axis

Further we used miRanda to analyze the circRNA/miRNA/mRNA axis that was consistent with the expression expectation. As shown in Fig. 4, There were binding sites between chr3:113195876|113197193 and rno-miR-30c-1-3p, rno-miR-30c-1-3p and Gata4, chr1:126188351|126195625 and rno-miR-153-5p, rno-miR-153-5p and Diaph3, chr5:122655270|122671094 and rno-miR-185-3p, rno-miR-185-3p and Pigr. Based on the results of qRT-PCR and bioinformatics analysis, we found that chr3:113195876|113197193/rno-miR-30c-1-3p/Gata4, chr1:126188351|126195625/rno-miR-153-5p/Diaph3 axis may participate in the progress of pBOO. Although we confirmed the circRNA/miRNA/mRNA axis in pBOO, whether the circRNA/miRNA/mRNA axises are involved in pBOO requires further investigation.

Fig. 4
figure 4

miRanda analyzed the binding sites of circRNA/miRNA/mRNA axis

Full size image

Discussion

pBOO occurs in more than 20% of adults and may lead to changes in bladder structure and function [28]. However, pBOO mechanism is still unclear. Studies have shown that circRNAs can act as "miRNA sponge", and the vital regulatory role of circRNAs in miRNA has attracted increasing attention [29]. Few studies have been conducted on mRNAs profile and circRNA-miRNA-mRNA network in the mechanism of pBOO. In order to reveal the biological function of circRNA-miRNA-mRNA and discover new transcripts in pBOO, we performed high-throughput sequencing and bioinformatics studies in the pBOO model to fill in the gaps.

It is well known that mRNA degradation plays a critical part in the post-transcriptional regulation after gene expression. miRNAs are key elements in mRNA degradation and ceRNAs [30]. CeRNA has a significant influence on the formation and progression of cancers by regulating mRNA expression. The discovery of circRNAs add new complexity to the regulation of gene expression mainly through epigenetic control of circRNA-miRNA-mRNA axis [31]. It has been reported that many regulatory miRNAs are involved in bladder pathology and function [32, 33]. Various miRNAs have been shown to be related to the bladder remodeling process caused by pBOO [34]. In contractile bladders from pBOO patients, the down-regulation of miR-199a-5p promotes the development of the disease [35]. In this research, we constructed the circRNA-miRNA-mRNA ceRNA network to study its role in pBOO. Our co-expression network is the primary way to predict the function of circRNA-miRNA-mRNA.

To better explain the effect of significantly dysregulated mRNA expression, we screened the miRNAs and circRNAs origin genes associated with bladder function. From the ceRNA network, we can conclude that circRNAs with different expressions are involved in pBOO through sponge-related miRNAs. Therefore, genes involved in the ceRNA network can help us understand the mechanism of the occurrence and development of pBOO. Combined with clinical data, these RNAs also have potential biomarkers for the diagnosis and prognosis of pBOO. In order to systematically and comprehensively understand the potential function of mRNA in pBOO, we conducted GO and KEGG pathway analysis of 571 differentially expressed mRNAs. Based on our sequencing results, we found that differentially regulated mRNAs were significantly enriched in cellular process, single-organism process, cell etc. KEGG pathway analysis showed that these differentially expressed mRNAs are involved in metabolic pathways, cell adhesion molecules (CAMs), and HTLV-I infection, etc. However, these interesting findings should be further confirmed in future studies.

In the ceRNA network, we selected four circRNA-miRNA-mRNAs, chr3:113195876|113197193/rno-miR-30c-1-3p/Gata4, chr5:122655270|122671094/rno-miR-185-3p/Pigr, chr1:126188351|126195625/rno-miR-153-5p/Diaph3, and chr9:81258380|81275269/rno-miR-135b-5p/Pigr, and qRT-PCR was performed to detect their expression. Compared with the sham group, the expression of these detected RNAs is different in pBOO group. Previous studies found that miR-30c-1-3p inhibited the resistance of prostate cancer to androgen ablation therapy by targeting androgen receptor variant 7 [36]. CircRNA_000203 aggravates cardiac hypertrophy by inhibiting the binding of miR-26b-5p and miR-140-3p to Gata4 [37]. Our results suggest that chr3:113195876|113197193 and Gata4 were down-regulated, while rno-miR-30c-1-3p was up-regulated in pBOO group. Hsa_circ_0088233 attenuate the proliferation, migration and invasion of prostate cancer cells by targeting hsa-miR-185-3p [38]. Polymerized immunoglobulin receptor (PIGR) plays an oncogenic role in hepatocellular carcinoma through activation of ribosomal pathways [39]. We found that chr5:122655270|122671094, rno-miR-185-3p were up-regulated, while Pigr was down-regulated in pBOO group. This showed chr5:122655270|122671094/rno-miR-185-3p/Pigr may not be through ceRNA mechanisms regulating pBOO.

It has been reported that miR-153-5p promotes the sensitivity of colorectal cancer cells to oxaliplatin through targeting Bcl-2 mediated autophagy pathway [40]. The gene encoding the cytoskeleton modulator DIAPH3 is lost frequently in metastatic prostate cancer, and DIAPH3 silencing induces a shift to an amoeba-like tumor phenotype in a variety of cellular settings. It is accompanied by an increase in tumor cell migration, invasion and metastasis [41]. Our research showed that chr1:126188351|126195625, Diaph3 were up-regulated, while rno-miR-153-5p was down-regulated in pBOO group. MiR-135b-5p has been found to play an important role in ovarian cancer, gastric cancer and other diseases [42, 43]. We found that chr9:81258380|81275269, Pigr were down-regulated, while rno-miR-135b-5p was up-regulated in pBOO group. There results suggest that chr3:113195876|113197193/rno-miR-30c-1-3p/Gata4, chr1:126188351|126195625/ rno-miR-153-5p/Diaph3 axis may play a significant role in the pathogenesis of pBOO, and they may be new molecular biomarkers of pBOO. However, this study still has some limitations and further investigation is needed to verify the exact role of the identified circRNA/miRNA/mRNA axis in the pathogenesis of pBOO.

Conclusion

Based on high-throughput sequencing and bioinformatics analysis, we found chr3:113195876|113197193/rno-miR-30c-1-3p/Gata4, chr1:126188351|126195625/rno-miR-153-5p/Diaph3 axis may be involved in the progress of the pBOO. This may be valuable for the diagnosis and treatment of pBOO and may lead to the discovery of new potential biomarkers. Further study of the functions of these RNAs will help us to understand the mechanism and progression of pBOO.

Availability of data and materials

The datasets generated and/or analysed during the current study are available in online repositories. The circRNA sequencing data are available via SRA data (BioProject Accession Number: PRJNA772547).

Abbreviations

pBOO:

Partial bladder outlet obstruction

BPH:

Benign prostatic hyperplasia

CAMs:

Cell adhesion molecules

circRNA:

Circular RNA

miRNA:

MicroRNA

ceRNA:

Competing endogenous RNA

GO:

Gene ontology

KEGG:

Kyoto Encyclopedia of Genes and Genomes

qRT-PCR:

Quantitative Real-time PCR

SD:

Standard deviation

ANOVA:

Analysis of variance

BP:

Biological processes

CC:

Cellular components

MF:

Molecular functions

PIGR:

Polymerized immunoglobulin receptor

References

  1. Albisinni S, Biaou I, Marcelis Q, Aoun F, De Nunzio C, Roumeguère T. New medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and future perspectives. BMC Urol. 2016;16(1):58.

    Article  PubMed  PubMed Central  Google Scholar 

  2. MacDonald D, McNicholas TA. Drug treatments for lower urinary tract symptoms secondary to bladder outflow obstruction: focus on quality of life. Drugs. 2003;63(18):1947–62.

    Article  CAS  PubMed  Google Scholar 

  3. Kai W, Lin C, Jin Y, Ping-Lin H, Xun L, Bastian A, et al. Urethral meatus stricture BOO stimulates bladder smooth muscle cell proliferation and pyroptosis via IL-1β and the SGK1-NFAT2 signaling pathway. Mol Med Rep. 2020;22(1):219–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mirone V, Imbimbo C, Longo N, Fusco F. The detrusor muscle: an innocent victim of bladder outlet obstruction. Eur Urol. 2007;51(1):57–66.

    Article  PubMed  Google Scholar 

  5. Hughes FM Jr, Hill HM, Wood CM, Edmondson AT, Dumas A, Foo WC, et al. The NLRP3 inflammasome mediates inflammation produced by bladder outlet obstruction. J Urol. 2016;195(5):1598–605.

    Article  CAS  PubMed  Google Scholar 

  6. Lin WY, Wu SB, Lin YP, Chang PJ, Levin RM, Wei YH. Reversing bladder outlet obstruction attenuates systemic and tissue oxidative stress. BJU Int. 2012;110(8):1208–13.

    Article  PubMed  Google Scholar 

  7. Wang N, Duan L, Ding J, Cao Q, Qian S, Shen H, et al. MicroRNA-101 protects bladder of BOO from hypoxia-induced fibrosis by attenuating TGF-β-smad2/3 signaling. IUBMB Life. 2019;71(2):235–43.

    CAS  PubMed  Google Scholar 

  8. Ghosal S, Das S, Sen R, Chakrabarti J. HumanViCe: host ceRNA network in virus infected cells in human. Front Genet. 2014;5:249.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Zhou DN, Ye CS, Deng YF. CircRNAs: potency of protein translation and feasibility of novel biomarkers and therapeutic targets for head and neck cancers. Am J Transl Res. 2020;12(5):1535–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Rong D, Sun H, Li Z, Liu S, Dong C, Fu K, et al. An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget. 2017;8(42):73271–81.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Su Y, Yi Y, Li L, Chen C. circRNA-miRNA-mRNA network in age-related macular degeneration: from construction to identification. Exp Eye Res. 2021;203:108427.

    Article  CAS  PubMed  Google Scholar 

  12. Chen LL. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 2016;17(4):205–11.

    Article  CAS  PubMed  Google Scholar 

  13. Wang M, Yu F, Li P. Circular RNAs: characteristics, function and clinical significance in hepatocellular carcinoma. Cancers (Basel). 2018;10(8):258.

    Article  PubMed  Google Scholar 

  14. Cao M, Zhang L, Wang JH, Zeng H, Peng Y, Zou J, et al. Identifying circRNA-associated-ceRNA networks in retinal neovascularization in mice. Int J Med Sci. 2019;16(10):1356–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Wang B, Wu J, Huang Q, Yuan X, Yang Y, Jiang W, et al. Comprehensive analysis of differentially expressed lncRNA, circRNA and mRNA and their ceRNA networks in mice with severe acute pancreatitis. Front Genet. 2021;12:625846.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hrdlickova R, Toloue M, Tian B. RNA-Seq methods for transcriptome analysis. Wiley Interdiscip Rev RNA. 2017;8(1):e1364.

    Article  Google Scholar 

  17. Hedlund E, Deng Q. Single-cell RNA sequencing: technical advancements and biological applications. Mol Asp Med. 2018;59:36–46.

    Article  CAS  Google Scholar 

  18. Monastyrskaya K, Sánchez-Freire V, Hashemi Gheinani A, Klumpp DJ, Babiychuk EB, Draeger A, et al. miR-199a-5p regulates urothelial permeability and may play a role in bladder pain syndrome. Am J Pathol. 2013;182(2):431–48.

    Article  CAS  PubMed  Google Scholar 

  19. Ekman M, Bhattachariya A, Dahan D, Uvelius B, Albinsson S, Swärd K. Mir-29 repression in bladder outlet obstruction contributes to matrix remodeling and altered stiffness. PLoS ONE. 2013;8(12):e82308.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Zhu B, Kang Z, Zhu S, Zhang Y, Lai X, Zhou L, et al. Multi-omics characterization of circular RNA-encoded novel proteins associated with bladder outlet obstruction. Front Cell Dev Biol. 2022;9:772534.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kanno Y, Mitsui T, Kitta T, Moriya K, Tsukiyama T, Hatakeyama S, et al. The inflammatory cytokine IL-1β is involved in bladder remodeling after bladder outlet obstruction in mice. Neurourol Urodyn. 2016;35(3):377–81.

    Article  CAS  PubMed  Google Scholar 

  22. Bschleipfer T, Nandigama R, Moeller S, Illig C, Weidner W, Kummer W. Bladder outlet obstruction influences mRNA expression of cholinergic receptors on sensory neurons in mice. Life Sci. 2012;91(21–22):1077–81.

    Article  CAS  PubMed  Google Scholar 

  23. Patel R, Jain M. NGS QC Toolkit: a toolkit for quality control of next generation sequencing data. PLoS ONE. 2012;7(2):e30619.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12(4):357–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Shen S, Kong J, Qiu Y, Yang X, Wang W, Yan L. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis. J Cell Biochem. 2019;120(6):10069–81.

    Article  CAS  PubMed  Google Scholar 

  26. Klopfenstein D, Zhang L, Pedersen BS, Ramírez F, Vesztrocy AW, Naldi A, et al. GOATOOLS: a Python library for gene ontology analyses. Sci Rep. 2018;8(1):10872.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Li C-B, Wang H-F, Feng Z-K, Fu Y-B, Zhang J, Qin J-Y. Identification of immune-related genes for Hepatocellular Carcinoma: a study based on TCGA data. J Men’s Health. 2021;17(2):101–13.

    Article  Google Scholar 

  28. Niemczyk G, Fus L, Czarzasta K, Jesion A, Radziszewski P, Gornicka B, et al. Expression of toll-like receptors in the animal model of bladder outlet obstruction. Biomed Res Int. 2020;2020:6632359.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–8.

    Article  CAS  PubMed  Google Scholar 

  30. Li M, Liu Y, Zhang X, Liu J, Wang P. Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer. Gene. 2018;677:189–97.

    Article  CAS  PubMed  Google Scholar 

  31. Venø MT, Hansen TB, Venø ST, Clausen BH, Grebing M, Finsen B, et al. Spatio-temporal regulation of circular RNA expression during porcine embryonic brain development. Genome Biol. 2015;16:245.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Duan LJ, Qi J, Kong XJ, Huang T, Qian XQ, Xu D, et al. MiR-133 modulates TGF-β1-induced bladder smooth muscle cell hypertrophic and fibrotic response: implication for a role of microRNA in bladder wall remodeling caused by bladder outlet obstruction. Cell Signal. 2015;27(2):215–27.

    Article  CAS  PubMed  Google Scholar 

  33. Hashemi Gheinani A, Burkhard FC, Rehrauer H, Aquino Fournier C, Monastyrskaya K. MicroRNA MiR-199a-5p regulates smooth muscle cell proliferation and morphology by targeting WNT2 signaling pathway. J Biol Chem. 2015;290(11):7067–86.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Duan LJ, Cao QF, Xu D, Liu HL, Qi J. Bioinformatic analysis of microRNA-mRNA expression profiles of bladder tissue induced by bladder outlet obstruction in a rat model. Mol Med Rep. 2017;16(4):4803–10.

    Article  CAS  PubMed  Google Scholar 

  35. Koeck I, Hashemi Gheinani A, Baumgartner U, Vassella E, Bruggmann R, Burkhard FC, et al. Tumor necrosis factor-α initiates miRNA-mRNA signaling cascades in obstruction-induced bladder dysfunction. Am J Pathol. 2018;188(8):1847–64.

    Article  CAS  PubMed  Google Scholar 

  36. Chen W, Yao G, Zhou K. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7. J Cell Biochem. 2019;120(8):14055–64.

    Article  CAS  PubMed  Google Scholar 

  37. Li H, Xu JD, Fang XH, Zhu JN, Yang J, Pan R, et al. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovasc Res. 2020;116(7):1323–34.

    Article  CAS  PubMed  Google Scholar 

  38. Deng ZH, Yu GS, Deng KL, Feng ZH, Huang Q, Pan B, et al. Hsa_circ_0088233 alleviates proliferation, migration, and invasion of prostate cancer by targeting hsa-miR-185-3p. Front Cell Dev Biol. 2020;8:528155.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Zhang Y, Zhang J, Chen X, Yang Z. Polymeric immunoglobulin receptor (PIGR) exerts oncogenic functions via activating ribosome pathway in hepatocellular carcinoma. Int J Med Sci. 2021;18(2):364–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. He Y, Zhang L, Tan F, Wang LF, Liu DH, Wang RJ, et al. MiR-153-5p promotes sensibility of colorectal cancer cells to oxaliplatin via targeting Bcl-2-mediated autophagy pathway. Biosci Biotechnol Biochem. 2020;84(8):1645–51.

    Article  CAS  PubMed  Google Scholar 

  41. Kim J, Morley S, Le M, Bedoret D, Umetsu DT, Di Vizio D, et al. Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: potential effects on the tumor microenvironment. Cancer Biol Ther. 2014;15(4):409–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Ren R, Wu J, Zhou MY. MiR-135b-5p affected malignant behaviors of ovarian cancer cells by targeting KDM5B. Eur Rev Med Pharmacol Sci. 2020;24(22):11469.

    CAS  PubMed  Google Scholar 

  43. Shao L, Chen Z, Soutto M, Zhu S, Lu H, Romero-Gallo J, et al. Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer. FASEB J. 2019;33(1):264–74.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by the grants from the National Natural Science Foundation of China (No. 81900688, to B.Z., No. 81802551, to Y.Z, No. 82270815,J.Z), the Natural Science Foundation of Guangdong Province (2016A030307033, to J.Z., 2019A1515011107 to B.Z.), Chinese Postdoctoral Science Foundation (2020M672593, to Y.Z.), the Medical Research Foundation of Guangdong Province (A2019473, to B. Z, B2020011, to Y.Z.), the Science and Technology Foundation of Qingyuan City (2020KJJH009, to B.Z.), and the Medical Research Foundation of Qingyuan People's Hospital (No. 20190205, to B.Z).

Author information

Author notes

  1. Baoyi Zhu, Jun Gao and Yuying Zhang have contributed equally to this work

Authors and Affiliations

  1. Department of Urology, The Sixth Affiliated Hospital of Guangzhou Medical University (Qingyuan People’s Hospital), B24 Yinquan Road, Qingcheng, Qingyuan, 511500, Guangdong, People’s Republic of China

    Baoyi Zhu, Baojian Liao, Sihua Zhu, Chunling Li, Junhao Liao, Jianjia Liu, Chonghe Jiang & Jianwen Zeng

  2. Department of Basic Medical Research, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan, 511518, Guangdong, People’s Republic of China

    Jun Gao

  3. Department of Child Health Care, Shenzhen Longhua Maternity and Child Health Care Hospital, Shenzhen, 518000, Guangdong, People’s Republic of China

    Yuying Zhang

  4. Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510700, Guangdong, People’s Republic of China

    Baojian Liao

Authors
  1. Baoyi Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuying Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Baojian Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sihua Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chunling Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Junhao Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jianjia Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Chonghe Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jianwen Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

BZ and JZ designed the study. JG and YZ, BL performed statistical analysis. SZ and CL provided technical support for data analysis. JL, JL and CJ performed experiments. BZ and JL wrote the main manuscript. BZ supervised the study. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Jianwen Zeng.

Ethics declarations

Ethics approval and consent to participate

This animal experiment was approved by Experimental Animal Care and Usage Committee of the Six Affiliated Hospital of Guangzhou Medical University (Qingyuan People’s Hospital) (Qingyuan, China). The study was carried out in compliance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines. All methods are carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

The authors declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhu, B., Gao, J., Zhang, Y. et al. CircRNA/miRNA/mRNA axis participates in the progression of partial bladder outlet obstruction. BMC Urol 22, 191 (2022). https://doi.org/10.1186/s12894-022-01132-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12894-022-01132-2

Keywords

  • circRNA/miRNA/mRNA
  • ceRNA
  • Bladder outlet obstruction
  • mRNA sequencing

BMC Urology

ISSN: 1471-2490

Contact us